Data Collection for Patients With Low Grade Ovarian Carcinoma
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The goal of this psychosocial research study is to collect information on patients with one of the above-mentioned low-grade tumors. Researchers want to maintain these patients' information in a research database to help learn and better understand these tumor types and to help develop better treatments for them.
| Condition | Intervention |
|---|---|
|
Ovarian Cancer Peritoneum Tumors |
Behavioral: Data Collection |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort |
| Official Title: | Data Collection for Patients With Low Grade Ovarian Carcinoma |
- Data Collection for Patients with Low Grade Ovarian Carcinoma [ Time Frame: 28 Years ] [ Designated as safety issue: No ]
Biospecimen Retention: Samples With DNA
If patient gives consent, tumor tissue left over from earlier surgery or surgeries that is preserved in wax or on glass slides will be stored in a research tissue bank.
| Estimated Enrollment: | 1000 |
| Study Start Date: | May 2006 |
| Estimated Primary Completion Date: | May 2034 (Final data collection date for primary outcome measure) |
| Groups/Cohorts | Assigned Interventions |
|---|---|
| Ovarian Cancer Data Collection |
Behavioral: Data Collection
Data collection from ovarian cancer patients seen at M.D. Anderson since January, 1950.
|
Detailed Description:
Low-grade tumors of female organs are considered rare. Because of this, doctors do not know the best treatment for these kinds of tumors. Researchers want to learn more about patients' experience with these types of cancer to help find ways to develop better therapies to treat them.
If you agree to take part in this study, information about your type of cancer, the type of treatment you had or are having, and details about your follow-up care will be entered into a research database. These data will be collected from patients seen at MD Anderson since January, 1950. This information will serve as a basis for research studies about patients with low-grade ovarian tumors.
Your data will mostly come from your MD Anderson medical record. However, information may also be requested from you, your local doctor, or an outside hospital. Information collected from sources other than MD Anderson will be included in your MD Anderson medical record as well as entered into this study's database.
Information may be directly collected from you, if there are additional questions not provided in your medical records, if your information is not complete, or if your information collected from other sources does not match what is in your MD Anderson medical record.
To help ensure confidentiality, the database will be password-protected with access strictly limited to study staff.
This research database will be updated at least once a year to include information about your current treatment and/or follow-up care. This information is usually collected from your MD Anderson medical record, or it may be necessary to contact you directly. This information will be collected indefinitely. If you wish to end your participation in this study, you may request that your data remain in the database or that your information be deleted from the database.
This is an investigational study. Up to 1,000 patients will take part in this study. All will be enrolled at MD Anderson.
Eligibility| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Department of Gynecologic Oncology or the Department of Gynecologic Medical Oncology at UT MD Anderson Cancer Center in Houston, Texas
Inclusion Criteria:
All patients seen at M.D. Anderson Cancer Center with the following tumor types or diagnosis are eligible for inclusion in this database. This includes patients whose disease progressed to a higher-grade carcinoma since the time of original diagnosis:
- Ovarian tumor of low malignant potential,
- Low-grade serous carcinoma of the ovary,
- Primary peritoneal tumor of low malignant potential,
- Low-grade serous carcinoma of the peritoneum,
- Psammocarcinoma
Exclusion Criteria: None
Contacts and Locations| Contact: Lisa Nathan | 713-745-3837 |
| United States, Texas | |
| UT MD Anderson Cancer Center | Recruiting |
| Houston, Texas, United States, 77030 | |
| Principal Investigator: David Gershenson, MD | |
| Principal Investigator: | David Gershenson, MD | M.D. Anderson Cancer Center |
More Information
Additional Information:
No publications provided
| Responsible Party: | M.D. Anderson Cancer Center |
| ClinicalTrials.gov Identifier: | NCT00488878 History of Changes |
| Other Study ID Numbers: | 2006-0137 |
| Study First Received: | June 18, 2007 |
| Last Updated: | March 15, 2013 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by M.D. Anderson Cancer Center:
|
Ovarian Cancer Ovarian Carcinoma Low-Grade Serous Carcinoma Low Malignant Potential |
Peritoneum Tumors Psammocarcinoma Data Collection Research Database |
Additional relevant MeSH terms:
|
Carcinoma Ovarian Neoplasms Neoplasms, Glandular and Epithelial Neoplasms by Histologic Type Neoplasms Endocrine Gland Neoplasms Neoplasms by Site |
Ovarian Diseases Adnexal Diseases Genital Diseases, Female Genital Neoplasms, Female Urogenital Neoplasms Endocrine System Diseases Gonadal Disorders |
ClinicalTrials.gov processed this record on June 18, 2013